BioNTech
BNTX
BNTX
318 hedge funds and large institutions have $6.01B invested in BioNTech in 2022 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 102 increasing their positions, 84 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
318
Holders Change
+55
Holders Change %
+20.91%
% of All Funds
5.13%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.11%
New
75
Increased
102
Reduced
84
Closed
17
Calls
$349M
Puts
$421M
Net Calls
-$71.2M
Net Calls Change
+$60.9M
Top Buyers
| 1 |
BlackRock
New York
|
$309M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$1.16B |
| 3 |
Capital World Investors
Los Angeles,
California
|
$311M |
| 4 |
Renaissance Technologies
New York
|
$49.8M |
| 5 |
AAM
Abeille Asset Management
France
|
$46M |
